CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bone Care International LLC v. Pentech Pharmaceuticals, Inc.

1:08-cv-01083

Overview

Case Number 1:08-cv-01083
Filing Date 2008-02-21
Status Terminated
Termination Date 2012-12-14
Court District Court, N.D. Illinois (ilnd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Plaintiff

Counter Claimant

Cobrek Pharmaceuticals, Inc. Operating Company

Represented By

3 Attorneys Listed

Court & Judges

Court

District Court, N.D. Illinois (ilnd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2009-07-16
1:09-cv-00524

Bone Care International LLC v. Sandoz Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6903083
Stabilized hydroxyvitamin D
Filed: 2002-08-20
Issued: 2005-06-07
Expired (Term Ended)
Expires: 2022-08-20
US5602116
Method for treating and preventing secondary hyperparathyroidism
Filed: 1995-04-03
Issued: 1997-02-11
Expired (Term Ended)
Expires: 2015-04-03

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

186

Dispositive

60

Granted

8

Denied

2

Pending / Review

164

Motions by Category

Claim Construction / Markman Filing 39 Procedural / Extension Motion 52 Motion to Compel Discovery 8 Motion to Dismiss 15 Motion to Strike / Sanctions 25 Motion to Stay 2 Motion for Summary Judgment (Invalidity) 7 Motion for Summary Judgment (Rule 56) 38

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Pending / Under Review
MINUTE entry before Honorable Robert M. Dow, Jr: Pursuant to Memorandum Opinion and Order, dated 3/29/2012, the Court denies Defendants motion for summary judgm...
Entry #650 • 2012-03-29 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
WRITTEN Opinion entered by the Honorable Robert M. Dow, Jr on 3/30/2011: Before the Court are Defendants Pentech Pharmaceuticals, Inc. and Cobrek Pharmaceutic...
Entry #643 • 2011-03-30 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
SEALED MOTION by Defendants Cobrek Pharmaceuticals, Inc., Pentech Pharmaceuticals, Inc., Counter Claimants Cobrek Pharmaceuticals, Inc., Pentech Pharmaceuticals...
Entry #641 • 2011-03-21 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
MINUTE entry before Honorable Robert M. Dow, Jr: Defendants motion 315 to deem admitted certain allegations that Defendants included in the statement of facts a...
Entry #640 • 2011-03-18 Document →
Motion for Summary Judgment (Rule 56) Granted
RESPONSE to Defendants' motions to amend or have reconsidered Order granting Plaintiffs' motion for summary judgment on Defendants' counterclaim "D" (D.I. 496) ...
Entry #514 • 2010-09-28 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
MOTION by Defendants Cobrek Pharmaceuticals, Inc., Pentech Pharmaceuticals, Inc., Counter Claimants Cobrek Pharmaceuticals, Inc., Pentech Pharmaceuticals, Inc.,...
Entry #513 • 2010-09-27 Document →

Docket Entries

(698 total)
Pleading / Complaint

COMPLAINT filed by Bone Care International LLC, Genzyme Corporation; Filing fee $ 350. (Attachments: # 1 Exhibit A# 2 Exhibit B) (td, ) (Entered: 02/22/2008)

Entry #1 • 2008-02-21
1
Pleading / Complaint

COMPLAINT filed by Bone Care International LLC, Genzyme Corporation; Filing fee $ 350. (Attachments: # 1 Exhibit A# 2 Exhibit B) (td, ) (Entered: 02/22/2008)

Entry #1 • 2008-02-21
2
Pleading / Complaint

COMPLAINT filed by Bone Care International LLC, Genzyme Corporation; Filing fee $ 350. (Attachments: # 1 Exhibit A# 2 Exhibit B) (td, ) (Entered: 02/22/2008)

Entry #1 • 2008-02-21
2

CIVIL Cover Sheet. (td, ) (Entered: 02/22/2008)

Entry #2 • 2008-02-21
1

ATTORNEY Appearance for Plaintiffs Bone Care International LLC, Genzyme Corporation by Sarah R. Wolff. (td, ) (Entered: 02/22/2008)

Entry #3 • 2008-02-21
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc